Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients
Public ClinicalTrials.gov record NCT00064701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (Cyclosporine)/MMF in de Novo Kidney Transplant Recipients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and efficacy of tacrolimus/mycophenolate mofetil (MMF), cyclosporine/MMF and tacrolimus modified release/MMF in de novo kidney transplant recipients.
Study identification
- NCT ID
- NCT00064701
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 668 participants
Conditions and interventions
Conditions
Interventions
- Tacrolimus Modified Release (MR) Drug
- Tacrolimus Drug
- cyclosporine microemulsion Drug
- mycophenolate mofetil Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2003 (Type not available)
- Primary completion
- Mar 2005 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Dec 5, 2013
2003 – 2009
United States locations
- U.S. sites
- 48
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Mobile | Alabama | 36617 | — |
| Not listed | Loma Linda | California | 92354 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Los Angeles | California | 90058 | — |
| Not listed | Los Angeles | California | 90095-7306 | — |
| Not listed | Palo Alto | California | 94304 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Denver | Colorado | 80262 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Gainesville | Florida | 32610-0224 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Boston | Massachusetts | 02214 | — |
| Not listed | Ann Arbor | Michigan | 48109-0364 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Livingston | New Jersey | 07039 | — |
| Not listed | New Brunswick | New Jersey | 08901 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | Buffalo | New York | 14203 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | Valhalla | New York | 10595 | — |
| Not listed | Chapel Hill | North Carolina | 27599-7211 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Portland | Oregon | 97239-2940 | — |
| Not listed | Harrisburg | Pennsylvania | 17104 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Nashville | Tennessee | 37212-4750 | — |
| Not listed | Dallas | Texas | 75235 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229-3900 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Fairfax | Virginia | 22031 | — |
| Not listed | Madison | Wisconsin | 53792-7375 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00064701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00064701 live on ClinicalTrials.gov.